| Literature DB >> 34912897 |
Maroof Ali1, Hidayat Hussain2, Amjad Hussain3, Abdur Rauf4, Wahid Hussain5, Manzoor Ullah6, Safdar Abbas7, Yahya S Al-Awthan8,9, Omar Bahattab8, Muhammad Khan3, Ahmed Olatunde10, Zainab M Almarhoon11, Yahia N Mabkhot12, Mohammed M Alshehri13, Sevgi Durna Daştan14,15, Mohamed Fawzy Ramadan16,17, Javad Sharifi-Rad18.
Abstract
Investigation on medicinal plants' therapeutic potential has gained substantial importance in the discovery of novel effective and safe therapeutic agents. The present study is aimed at investigating the hepatoprotective potential of Seriphidium kurramense methanolic extract (SKM) against carbon tetrachloride- (CCl4-) induced hepatotoxicity in rats. S. kurramense is one of the most imperative plants for its various pharmacological activities. Therefore, this study was aimed at evaluating the hepatoprotective potential against CCl4-induced liver toxicity. The serum samples were analyzed for alanine aminotransferase (ALT) and aspartate aminotransferase (AST) together with the oxidative stress mediator levels as nitric oxide (NO), malondialdehyde (MDA), glutathione (GSH), reduced glutathione (GSH), and superoxide dismutase (SOD) as well as peroxidation and H2O2 activity. CCl4 administration resulted in an elevated free radical generation, altered liver marker (AST and ALT) enzymes, reduced antioxidant enzyme, and increased DNA damage. Methanolic extract of S. kurramense decreased CCl4-induced hepatotoxicity by increasing the antioxidant status and reducing H2O2 and nitrate content generation as well as reducing DNA damage. Additionally, SKM reversed the morphological alterations induced by CCl4 in the SKM-treated groups. These results demonstrated that SKM displayed hepatoprotective activity against CCl4-induced hepatic damage in experimental rats.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34912897 PMCID: PMC8668277 DOI: 10.1155/2021/9026731
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Effect of S. kurramense on liver biomarkers.
| Treatment | ALT (mg/dL) | AST (mg/dL) | Albumin (mg/dL) | Globulin (mg/dL) | Tissue protein ( |
|---|---|---|---|---|---|
| Control (normal) | 38 ± 2.16e | 42 ± 2.16d | 4.47 ± 0.59a | 3.69 ± 0.38b | 3.26 ± 0.23a |
| DMSO+olive oil | 37 ± 2.16e | 43 ± 2.16d | 4.33 ± 0.81a | 3.69 ± 0.42b | 3.25 ± 0.32a |
| CCl4 (1 mL/kg) | 109 ± 4.19a | 106 ± 4.11a | 1.95 ± 0.29d | 4.07 ± 0.36a | 1.37 ± 0.16c |
| CCl4+silymarin | 96 ± 3.36b | 86 ± 4.61b | 3.07 ± 0.37b | 3.94 ± 0.54b | 2.67 ± 0.33b |
| CCl4+SKM (150 mg/mg) | 86 ± 4.42c | 84 ± 4.42b | 2.46 ± 0.14c | 3.17 ± 0.66b | 1.62 ± 0.42c |
| CCl4+SKM (300 mg/kg) | 72 ± 3.49d | 58 ± 3.49c | 3.14 ± 0.21b | 3.89 ± 0.19b | 2.75 ± 0.45b |
| SKM (150 mg/kg) | 38 ± 2.16e | 44 ± 2.16d | 4.14 ± 0.44a | 3.59 ± 0.31b | 3.41 ± 0.42a |
| SKM (300 mg/kg) | 39 ± 2.16e | 42 ± 2.16d | 4.22 ± 0.50a | 3.62 ± 0.46b | 3.31 ± 0.32a |
Values are expressed as mean ± SD (7). Values with different alphabet letters down the column indicate a significant difference (p < 0.05). SKM: Seriphidium Kurramense methanol extract.
Effect of S. Kurramense on antioxidant parameters.
| Treatment | CAT (U/min) | POD (U/min) | SOD (U/mg protein) | GSH ( |
|---|---|---|---|---|
| Control (normal) | 7.3 ± 0.82a | 9.38 ± 1.2a | 5.33 ± 0.75a | 22.46 ± 1.32a |
| DMSO+olive oil | 7.2 ± 0.78a | 9.32 ± 1.17a | 5.23 ± 0.86a | 22.41 ± 1.36a |
| CCl4 (1 mL/kg) | 2.36 ± 0.31d | 3.01 ± 0.33d | 2.03 ± 0.42d | 6.42 ± 0.72d |
| CCl4+silymarin | 5.4 ± 0.56b | 8.1 ± 1.12b | 4.12 ± 0.96b | 18.42 ± 2.16b |
| CCl4+SKM (150 mg/mg) | 4.6 ± 0.68c | 6.23 ± 0.85c | 3.78 ± 0.42c | 14.56 ± 1.11c |
| CCl4+SKM (300 mg/kg) | 5.9 ± 0.65b | 8.52 ± 1.23b | 4.36 ± 0.76b | 17.23 ± 1.26b |
| SKM (150 mg/kg) | 7.3 ± 0.72a | 9.28 ± 1.09a | 5.28 ± 0.62a | 22.32 ± 1.06a |
| SKM (300 mg/kg) | 7.1 ± 0.93a | 9.10 ± 1.11a | 5.24 ± 0.72a | 22.42 ± 1.42a |
SKM: Seriphidium kurramense methanol extract. Values expressed as mean ± SD (7). Means with different alphabet letters within the column indicate a significant difference (p < 0.05).
Effect of SKM on TBARS, nitrite, and H2O2 in CCl4-treated rats.
| Treatment | TBARS (nM/min/mg protein) | Nitrite ( | H2O2 ( |
|---|---|---|---|
| Control (normal) | 24.56 ± 2.16a | 49.24 ± 2.04d | 0.39 ± 0.09e |
| DMSO+olive oil | 24.47 ± 2.32a | 49.23 ± 2.25d | 0.38 ± 0.08e |
| CCl4 (1 mL/kg) | 47.22 ± 3.17b | 87.68 ± 4.22a | 1.03 ± 0.26a |
| CCl4+silymarin | 28.23 ± 1.42c | 56.23 ± 2.17c | 0.52 ± 0.11c |
| CCl4+SKM (150 mg/mg) | 30.26 ± 2.42c | 63.01 ± 2.23b | 0.75 ± 0.15b |
| CCl4+SKM (300 mg/kg) | 29.43 ± 2.17c | 58.23 ± 3.32c | 0.48 ± 0.08c |
| SKM (150 mg/kg) | 24.24 ± 1.32a | 47.67 ± 2.31d | 0.38 ± 0.09e |
| SKM (300 mg/kg) | 23.78 ± 2.36a | 48.03 ± 2.09d | 0.39 ± 0.11e |
SKM: Seriphidium kurramense methanol extract. Values expressed as mean ± SD (7). Means with different alphabet letters within the column indicate a significant difference (p < 0.05).
Figure 1The fluorescence photomicrograph of Seriphidium kurramense methanol extract effect on DNA of hepatic cells: (a) control group, (b) vehicle control, (c) CCl4 only, (d) CCl4+rutin, (e) CCl4+low dose (150 mg/kg), (f) CCl4+high dose (300 mg/kg), (g) low dose alone, and (h) high dose alone.
Effects of SKM on the genotoxic parameters in CCl4-treated rats.
| Treatment | Comet length ( | Head length ( | Tail length ( | % DNA in the head | % DNA in the tail | Tail moment ( |
|---|---|---|---|---|---|---|
| Control (normal) | 62.14 ± 3.6d | 55 ± 3.03a | 7.3 ± 1.11d | 91 ± 3.03a | 9.01 ± 1.16d | 31.51 ± 2.01c |
| DMSO+olive oil | 62.23 ± 3.4d | 55.5 ± 3.2a | 7.5 ± 1.02d | 90 ± 3.45a | 9.86 ± 1.37d | 31.42 ± 2.12c |
| CCl4 (1 mL/kg) | 86.21 ± 4.2a | 44 ± 3.33c | 42 ± 2.11a | 65 ± 2.12d | 35 ± 2.56a | 41.87 ± 2.07a |
| CCl4+silymarin | 65.27 ± 3.1c | 52.3 ± 3.1b | 13.9 ± 1.23c | 86 ± 3.16b | 14.1 ± 1.9c | 32.42 ± 2.01c |
| CCl4+SKM (150 mg/mg) | 73.03 ± 3.3b | 45 ± 3.42c | 19 ± 2.45b | 71.3 ± 3.1c | 29.5 ± 2.3b | 36.56 ± 2.02b |
| CCl4+SKM (300 mg/kg) | 65.78 ± 3.3c | 45.2 ± 2.3c | 20.58 ± 1.4b | 87.1 ± 3.2b | 12.87 ± 1.1c | 32.54 ± 2.04c |
| SKM (150 mg/kg) | 61.62 ± 1.6d | 54.3 ± 2.4a | 7.31 ± 1.9d | 91.2 ± 3.1a | 9.78 ± 1.5d | 30.50 ± 2.02c |
| SKM (300 mg/kg) | 62.23 ± 1.3d | 55.6 ± 2.2a | 7.63 ± 1.01d | 90.1 ± 4.1a | 9.71 ± 1.13d | 30.47 ± 2.04c |
SKM: Seriphidium kurramense methanol extract. Values expressed as mean ± SD (7). Means with different alphabet letters within the column indicate a significant difference (p < 0.05).
Figure 2Liver histopathological observations of control and treated groups at 40x: (a) control, (b) vehicle control, (c) CCl4 only, (d) CCl4+silymarin 200 mg/kg, (e) CCl4+SKM 150 mg/kg, (f) CCl4+SMM 300 mg/kg, (g) SKM 150 mg/kg, and (h) SKM 300 mg/kg.
Figure 3Mechanism of Seriphidium kurramense from traditional medicine to in vivo analysis.
Distribution of animal groups (each containing 6 rats).
| Group (control) | Given no treatment |
|---|---|
| Group 1 (control normal) | Normal healthy feeding |
| Group 2 DMSO+olive oil | Given 10% DMSO in olive oil orally (1 mL/kg rat body weight) |
| Group 3 (CCl4) | Given 30% CCl4 in olive oil i.p (1 mL/kg rat body weight) |
| Group 4 (silymirin+CCl4) | Given 30% CCl4 in olive oil i.p (1 mL/kg rat body weight)+silymarin (100 mg/mL in DMSO) orally |
| Group 5 (low dose+CCl4) | Given 30% CCl4 in olive oil i.p (1 mL/kg rat bodyweight)+ |
| Group 6 (high dose+CCl4) | Given 30% CCl4 in olive oil i.p (1 mL/kg rat bodyweight)+ |
| Group 7 (SKM) | Given only |
| Group 8 (SKM) | Given only |